loses

The closest look ever at the cell's machines

Today researchers in Germany announce they have finished the first complete analysis of the "molecular machines" in one of biology's most important model organisms: S. cerevisiae (baker's yeast). The study from the biotechnology company Cellzome, in collaboration with the European Molecular Biology Laboratory (EMBL), appears in this week's online edition of Nature. "To carry out their task...

Male contraception: One door opens, another closes

We have often heard that a new male contraceptive is "five to ten years" away. But are we getting any closer? The answer may finally be "yes." This week marked the announcement of one hot new lead and one dead end. Researchers in Italy and at the Population Council in New York have announced a breakthrough on a non-hormonal compound known as Adjudin (Nature...

Stanford-led study closes in on genes that may predispose some people to severe depression

Some people appear to be genetically predisposed to developing severe depression, but researchers have yet to pin down the genes responsible. Now, a specific region rife with promise has been located on one chromosome by a consortium of researchers working under Douglas Levinson, MD, professor of psychiatry and behavioral sciences at the Stanford University School of Medicine. "Thi...

loses at Biology Products

No data found

Search loses biology products at Google

Search loses biology products at Yahoo

Search loses biology products at Msn

loses at Biology Technology

DEMO 2003 Closes with Focus on Collaboration and Communication

Scottsdale, AZ - DEMO 2003 continued to buzz with innovation and excitement on its closing day, focusing on a myriad of new technologies that included timely next-generation systems designed to protect and defend the national IT infrastructure as well as collaboration tools and evolving email services. In addition to an array of new product demonstrations, technology leaders discussed the possibi...

Milwaukee software developer gains bottom line, loses waistline

And now, the route of that marathon has taken a sharp turn toward Europe and Asia. Psuik, founder and owner of <a href="http://www.developerone.c...

NimbleGen closes $8.2m venture round, bringing total to $50m

Madison biotech firm The company makes tools for genetic research. Its microarrays, basically slides that can have thousands of individual genetic samples on them arranged in a grid, allow scientists a...

BoneCare doubles options and profits as fiscal year closes

BoneCare's fourth-quarter net income has been reported...

loses at Medicine News

Russia warns against travel to Turkey, Iran closes border

Russians should avoid travelling to Turkey after seven confirmed cases of bird flu, the chief state epidemiologist Gennady Onishchenko said on Sunday // . Turkey is the sixth country where the deadly H5N1 bird flu virus has jumped from poultry to people, the first human infections outside eastern Asia. "I earnestly advise Russian citizens to refrain from travelling to Turkey,...

Cancer Patient Loses Embryo Appeal

Natallie Evans, who was left infertile after cancer treatment has lost her appeal to use frozen embryos to have a baby. The European Court of Human Rights rules against Ms Evans, who says that she is determined to have a baby. // "I'm still as determined to do whatever it takes to have a child of my own," she said after the verdict. "Howard may feel it's too late for him to change his mi...

Brunei Closes Primary Schools In A Bid To Contain Hand, Foot and Mouth Disease

BANDAR SERI BEGAWAN - Following in the steps of Malaysia, Brunei has quickly moved to prevent the spread of hand, foot and mouth viral disease and has ordered the closure of// all primary and nursery schools after the first death due to the disease was reported on Friday. The education ministry said that it was taking this precautionary measure after officials reported 32 cases and on...

Organic food loses its whole-grain image

Organic food no longer means just tough whole-grain products. The movement has burst out of the narrow milieu it originated from, and now products// are available that would have been unthinkable a few years ago. For decades organic food had the image of whole-grain muesli, rubbery tofu and tasteless vegetarian cutlets, but times are fast changing. In the larger towns and ci...

Cash-Strapped Hospital loses Top Surgeons

Mount Vernon, one of Britain’s prime plastic surgery units, is losing four of their senior consultants because of inadequate funds// to maintain the hospital. The four specialists, Douglas Harrison, Paul Smith, David Gault and Rajiv Grover were part of a team of nine experts at Mount Vernon Hospital in Northwood. As they leave services of the hospital would be dramatically reduced. <...

More>>

loses at Medicine Products

No data found

Search loses medicine products at Google

Search loses medicine products at Yahoo

Search loses medicine products at Msn

loses at Medicine Technology

AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting

Ozarelix improved LUTS symptoms and urine flow over 28-week period QUEBEC CITY, May 23, 2007 /PRNewswire-FirstCall/ - AEternaZentaris Inc. , a global biopharmaceutical company focused onendocrine therapy and oncology, today announced that its partnerSpectrum Pharmaceuticals presented an abstract outlining detailedPhase 2 results for AEterna Zentaris' fourth-generation luteinizinghormone-r...

terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles

Second generationpyridopyrazine-urea derivative compound series show highlyselective PI3K-inhibition which could be valuable for cancertreatment QUBEC CITY, Canada, April16, 2007 terna Zentaris Inc. (TSX: AEZ; Nasdaq:AEZS), a global, pure play biopharmaceutical company...

AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles

JMR-132 could provide a new therapeutic approach for the treatmentof early and metastatic breast cancer QUEBEC CITY, April 17, 2007 /PRNewswire-FirstCall/ - AEternaZentaris Inc. , a global, pure play biopharmaceutical companyfocused on endocrine therapy and oncology, today presented anabstract outlining in vivo data for its growth hormone-releasinghormone (GHRH) antagonist JMR-132 in brea...

AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles

Second generation pyridopyrazine-urea derivative compound seriesshow highly selective PI3K-inhibition which could be valuable forcancer treatment QUEBEC, April 16, 2007 /PRNewswire-FirstCall/ - AEterna ZentarisInc. , a global, pure play biopharmaceutical company focused onendocrine therapy and oncology, today presented an abstractoutlining first in vitro data on its pyridopyrazine derivat...